Search Results

Synthesis and Biological Study of 3-Butyl-1-(2,6-dichlorophenyl)-1H-[1,2,4]triazol- 5(4H)-one Derivatives as Anti-hypertension Drugs

Authors: Zhang, Yanchun; Zhou, Jinpei; Pan, Weihong; Wu, Xiaoming; Wang, Shuai

Source: Letters in Drug Design & Discovery, Volume 7, Number 1, January 2010 , pp. 18-22(5)

Publisher: Bentham Science Publishers

Amlodipine/Valsartan/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension

Author: Deeks, Emma D.

Source: American Journal of Cardiovascular Drugs, Volume 9, Number 6, 1 December 2009 , pp. 411-418(8)

Publisher: Adis International

Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism: A Prospective Cohort Study in Primary Care

Authors: Yajima, Ken; Shimada, Akira; Hirose, Hiroshi; Oikawa, Yoichi; Yamada, Satoru; Meguro, Shu; Irie, Junichiro; Irie, Seiko

Source: Clinical Drug Investigation, Volume 29, Number 12, 1 December 2009 , pp. 811-819(9)

Publisher: Adis International

Influence of endogenous angiotensin II on control of sympathetic nerve activity in human dehydration

Authors: Rabbitts, J. A.; Strom, N. A.; Sawyer, J. R.; Curry, T. B.; Dietz, N. M.; Roberts, S. K.; Kingsley-Berg, S. M.; Charkoudian, N.

Source: The Journal of Physiology, Volume 587, Number 22, November 2009 , pp. 5441-5449(9)

Publisher: Blackwell Publishing

Valsartan: More Than a Decade of Experience

Authors: Black, Henry R.; Bailey, Jacqueline; Zappe, Dion; Samuel, Rita

Source: Drugs, Volume 69, Number 17, 3 December 2009 , pp. 2393-2414(22)

Publisher: Adis International

Eprosartan: A Review of its Use in Hypertension

Author: Plosker, Greg L.

Source: Drugs, Volume 69, Number 17, 3 December 2009 , pp. 2477-2499(23)

Publisher: Adis International

Antagonist of the Type-1 ANG II receptor prevents against LPS-induced septic shock in rats

Authors: Hagiwara, Satoshi; Iwasaka, Hideo; Hidaka, Seigo; Hasegawa, Akira; Koga, Hironori; Noguchi, Takayuki

Source: Intensive Care Medicine, Volume 35, Number 8, August 2009 , pp. 1471-1478(8)

Publisher: Springer

Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts

Authors: Zhang, Guo-You; Li, Xuan; Yi, Cheng-Gang; Pan, Hua; He, Guo-Dong; Yu, Qing; Jiang, Liang-Fu; Xu, Wei-Hua; Li, Zhi-Jie; Ding, Jian; Lin, Ding-Sheng; Gao, Wei-Yang

Source: Experimental Dermatology, Volume 18, Number 11, November 2009 , pp. 947-953(7)

Publisher: Blackwell Publishing

Effects of AT1- and β-adrenergic receptor antagonists on TGF-β1-induced fibrosis in transgenic mice

Authors: Seeland, U.; Schäffer, A.; Selejan, S.; Hohl, M.; Reil, J.-C.; Müller, P.; Rosenkranz, S.; Böhm, M.

Source: European Journal of Clinical Investigation, Volume 39, Number 10, October 2009 , pp. 851-859(9)

Publisher: Blackwell Publishing

PREVENTION OF AORTIC ELASTIC LAMINA DEFECTS BY LOSARTAN IN APOLIPOPROTEIN E-DEFICIENT MOUSE

Authors: Chan, Elsa C; Jones, Gregory T; Dusting, Gregory J; Datla, Srinivasa R; Jiang, Fan

Source: Clinical and Experimental Pharmacology and Physiology, Volume 36, Number 9, September 2009 , pp. 919-924(6)

Publisher: Blackwell Publishing

Fixed-Dose Combinations as Initial Therapy for Hypertension: A Review of Approved Agents and a Guide to Patient Selection

Authors: Waeber, Bernard; Feihl, François; Ruilope, Luis M.

Source: Drugs, Volume 69, Number 13, 10 September 2009 , pp. 1761-1776(16)

Publisher: Adis International

Cardiovascular Effects of Losartan and Its Relevant Clinical Application

Authors: Xu, Feichao; Mao, Caiping; Hu, Yali; Rui, Can; Xu, Zhice; Zhang, Lubo

Source: Current Medicinal Chemistry, Volume 16, Number 29, October 2009 , pp. 3841-3857(17)

Publisher: Bentham Science Publishers

Sympathetic-mediated hypertension of awake juvenile rats submitted to chronic intermittent hypoxia is not linked to baroreflex dysfunction

Authors: Zoccal, Daniel B.; Bonagamba, Leni G. H.; Paton, Julian F. R.; Machado, Benedito H.

Source: Experimental Physiology, Volume 94, Number 9, September 2009 , pp. 972-983(12)

Publisher: Blackwell Publishing

Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System

Authors: Li, Huige; Forstermann, Ulrich

Source: Current Pharmaceutical Design, Volume 15, Number 27, September 2009 , pp. 3133-3145(13)

Publisher: Bentham Science Publishers

Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy

Authors: Kondrack, Robyn; Mohiuddin, Syed

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 9, September 2009 , pp. 1125-1134(10)

Publisher: Informa Healthcare

ROLE OF ACTIVATED INTRARENAL REACTIVE OXYGEN SPECIES AND RENIN-ANGIOTENSIN SYSTEM IN IgA NEPHROPATHY MODEL MICE

Authors: Ohashi, Naro; Katsurada, Akemi; Miyata, Kayoko; Satou, Ryousuke; Saito, Toshie; Urushihara, Maki; Kobori, Hiroyuki

Source: Clinical and Experimental Pharmacology and Physiology, Volume 36, Number 8, August 2009 , pp. 750-755(6)

Publisher: Blackwell Publishing

Costs of Eprosartan versus Diuretics for Treatment of Hypertension in a Geriatric Population: An Observational, Open-Label, Multicentre Study

Authors: Gregori, Joaquin A. Alvarez; Nuñez, Juan F. Macías; Domínguez-Gil, Alfonso

Source: Drugs & Aging, Volume 26, Number 7, 1 July 2009 , pp. 617-626(10)

Publisher: Adis International

One-Year Renal and Cardiac Effects of Bisoprolol versus Losartan in Recently Diagnosed Hypertensive Patients: A Randomized, Double-Blind Study

Authors: Parrinello, Gaspare; Paterna, Salvatore; Torres, Daniele; >Pietro Di Pasquale,; Mezzero, Manuela; >Gabriella La Rocca,; Cardillo, Mauro; Trapanese, Caterina; Caradonna, Mario; Licata, Giuseppe

Source: Clinical Drug Investigation, Volume 29, Number 9, 1 September 2009 , pp. 591-600(10)

Publisher: Adis International

EFFECTS OF COMBINATION THERAPY WITH PERINDOPRIL AND LOSARTAN ON LEFT VENTRICULAR REMODELLING IN PATIENTS WITH MYOCARDIAL INFARCTION

Authors: Li, Ling; Liu, Rui-Yun; Zhao, Xiao-Yan; Zhang, Jin-Ying; Jia, Min; Lu, Pei-Qi

Source: Clinical and Experimental Pharmacology and Physiology, Volume 36, Number 7, July 2009 , pp. 704-710(7)

Publisher: Blackwell Publishing

Investigational vasopressin receptor modulators in the pipeline

Authors: Favory, Raphaël; Salgado, Diamantino R; Vincent, Jean-Louis

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 8, August 2009 , pp. 1119-1131(13)

Publisher: Informa Healthcare